PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Question Time: Applying New Therapies for the Management of mTNBC
Visit https://www.peervoice.com/SCM860 to view the entire programme with slides. After completing “Question Time: Applying New Therapies for the Management of mTNBC”, participants will be able to: Apply the data for approved novel therapies in the context of a therapeutic strategy for patients with metastatic triple-negative breast cancer (mTNBC); Identify which patients with mTNBC may benefit from recently approved treatment options; and Describe strategies for optimising patient care in patients undergoing a treatment strategy with an antibody-drug conjugate for mTNBC.